harm reduction

Meeting minutes: Take home naloxone to reduce fatalities: scaling up a participatory intervention across Europe, October 2014

04.11.2014

These are the minutes from a meeting organised by the EMCDDA on 14 October 2014 in Lisbon, entitled 'Take home naloxone to reduce fatalities: scaling up a participatory intervention across Europe'. The...

Events

HCV Expert meeting ‘Scaling up action on HepC for PWID’

28.01.2020 to 30.01.2020

The EMCDDA is organising an expert meeting on Scaling up action on HepC for PWID, taking place in Lisbon in January 2020.

Lisbon, Portugal

EMCDDA expert meeting

Last updated : 05.12.2019

Rating: Unknown effectiveness

Needle and syringe programmes were analysed in a systematic review (ECDC/EMCDDA, 2018) and showed no significant effect in:

reducing injecting risk behaviours in prison.

Name of response option

Needle and syringe programmes (NSP)

Desired outcome(s)

reduce risk behaviours

Area(s)

Harm reduction

Specific substance or pattern of use

opioids

Target group(s) or setting(s)

PWID – people who inject drugs

References

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. Public health guidance on prevention and control of blood-borne viruses in prison settings. Stockholm: ECDC and EMCDDA; 2018.

Media library

An illustration of the range of models of drug checking available and their relative strengths

23.10.2017

Topic hub page

Drug checking

25.10.2019

Drug-checking services enable individual drug users to have their drugs chemically analysed, providing information on the content of the samples as well as advice, and, in some cases, counselling or brief interventions. Service aims...

Topic hub page

Drug consumption facilities

20.01.2020

Drug consumption facilities are places in which drug users can use illicit drugs under the supervision of medically trained staff. They exist in several European countries and are usually located in areas where...

Topic hub page

Take-home naloxone

07.10.2019

Naloxone is used worldwide in medical emergencies to reverse respiratory depression caused by opioid overdose. It has no effect on non-opioid drug overdoses, no dependency potential and a high safety margin. Discovered and patented...

Data